INVO Fertility, Inc. (NAYA Biosciences, Inc.) - 8-K Summary
Business Context and Reporting Period
This Form 8-K was filed by NAYA Biosciences, Inc. (trading symbol: NAYA) on March 24, 2025, reporting events that occurred on March 18, 2025. The filing addresses a corporate action regarding the company's capital structure. Note: While the request metadata references "INVO Fertility, Inc.", the filing text explicitly identifies the registrant as "NAYA Biosciences, Inc."
Key Financial Metrics
This filing is a Current Report regarding a corporate governance event and does not contain financial statements. Consequently, there are no reported values for revenue, profit, cash flow, margins, debt, or liquidity in this document.
Material Changes
The primary material change reported is the implementation of a 1-for-12 reverse stock split of the Company's Common Stock. Key details include:
- Effective Date: March 18, 2025, at 12:01 a.m. Eastern Time.
- Mechanism: Every 12 shares of Common Stock were reclassified and combined into one share.
- Authorized Shares: Adjusted proportionately to 4,166,667 shares.
- Equity Adjustments: Exercise prices and share counts for outstanding stock options and warrants were adjusted proportionately.
- Fractional Shares: No fractional shares were issued; holdings were rounded up to the next whole share.
- Trading: The stock continued to trade on The Nasdaq Capital Market under the symbol "NAYA" with a new CUSIP number (44984F609).
Guidance, Outlook, and Risks
The filing does not provide updated financial guidance, management commentary on future operations, or specific risk factors beyond the standard disclosure that the description of the Certificate of Change is qualified by reference to the full text of the document filed as Exhibit 3.1.
Investor Verification Checklist
- Verify the new CUSIP number (44984F609) for trading and settlement purposes.
- Confirm the adjusted number of shares held in brokerage accounts following the 1-for-12 split.
- Review the adjusted exercise prices and share quantities for any outstanding stock options or warrants.
- Check the full text of the Certificate of Change (Exhibit 3.1) for any additional legal stipulations.